Renovascular Disease in the Elderly

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry


Renovascular diseases (RVDs) that cause end-stage renal disease (ESRD) are inflammatory vasculitis, nephrosclerosis, RVD atheromatous and embolic disease. Renal artery stenosis is the cause of renovascular hypertension in at least 90%. Atherosclerosis involves 80% of the ostium and the proximal one-third of the renal artery. Renovascular hypertension and ischaemic nephropathy are most commonly seen in patients with atherosclerotic renal artery stenosis. Surgical procedures include PTRA and PTRAS (percutaneous renal artery angioplasty and stenting). This review summarises and provides an update in the management of renovascular disease.


Renovascular disease Renovascular hypertension Ischaemic nephropathy Atherosclerotic renal artery stenosis 


  1. 1.
    ACC/AHA Pocket Guideline-Management of patients with peripheral arterial diseases. March 2006.Google Scholar
  2. 2.
    Eardley KS, Lipkin GW. Atherosclerotic renal artery stenosis: is it worth diagnosing? J Hum Hypertens. 1999;13(4):217–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Bosmans JL, De Broe ME. Renovascular hypertension: diagnostic and therapeutic challenges. JBR-BTR. 2004;87(1):32–5.PubMedGoogle Scholar
  4. 4.
    Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51N.CrossRefPubMedGoogle Scholar
  5. 5.
    Sawicki PT, Kaiser S, Heinemann L, Frenzel H, Berger M. Prevalence of renal artery stenosis in diabetes mellitus-an autopsy study. J Intern Med. 1991;229:489–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Zierler RE, Bergelin RO, Polissar NL, Beach KW, Caps MT, Cantwell-Gab K, et al. Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch Intern Med. 1998;158:761–767.CrossRefPubMedGoogle Scholar
  7. 7.
    Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: Epidemiology, cardiovascular outcomes and clinical prediction rules. JASN. 2002;1:S179–S183.CrossRefGoogle Scholar
  8. 8.
    Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA, et al. Recurring pulmonary oedema in synchronous due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet. 1988;2:551–552.CrossRefPubMedGoogle Scholar
  9. 9.
    Walker F, Walker DA, Neilson M. Flash pulmonary oedema. Lancet. 2001; 358:556.CrossRefPubMedGoogle Scholar
  10. 10.
    Woolfson RG. Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis and intervention. Postgrad Med J. 2001;77:68–74.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Woolfson RG, Neild GH. The true clinical significance of renography in nephron-urology. Eur J Nucl Med. 1997;24:557–570.PubMedGoogle Scholar
  12. 12.
    Dawson DL. Non-invasive assessment of renal artery stenosis. Sem Vasc Surg 1996;9:172–181.Google Scholar
  13. 13.
    Krijen P, van Jaarsveld BC, Steyerberg EW, Man in’t Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;129:705–711.CrossRefGoogle Scholar
  14. 14.
    Klahr S. Role of dietary protein and blood pressure in the progression of renal disease. Kidney Int. 1990;49:1783–1786.CrossRefGoogle Scholar
  15. 15.
    UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38, BMJ. 1998;317:934–939.CrossRefGoogle Scholar
  16. 16.
    Girotra S, Murarka S, Migrino RQ. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Panminerva Med. 2012;54(2):71–81.PubMedGoogle Scholar
  17. 17.
    United States Renal Data System 1997. Annual Data Report. Am J Kidney Dis. 1997;30(Suppl1).Google Scholar
  18. 18.
    Geddes CC, Jardine AG. Diagnosis and treatment of atherosclerotic renal artery disease (ARAS). Minerva Urol Nefrol. 2002;54(1): 29–36.PubMedGoogle Scholar
  19. 19.
    Zahringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, et al. Sirolimus-eluting versus bare-metal profile stent for renal artery treatment (GREAT Trial), angiographic follow up after 6 months and clinical outcome up to 2 years. J Endovasc Ther. 2007;14:460–468.CrossRefPubMedGoogle Scholar
  20. 20.
    Cooper CJ. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117:2752–2760.CrossRefPubMedGoogle Scholar
  21. 21.
    Anand S, Johansen KL, Tamura MK. Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci. 2014;69A(3):315–322. Scholar
  22. 22.
    Zalai D, Szeifert L, Novsak M. Psychological distress and depression in patients with chronic kidney disease. Semin Dial. 2012;25(4):428–38.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations